Supplementary Table S6 from Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with <i>MDM2</i> Amplification: An Open-Label Phase Ib/II Study

<p>Targeted sequencing analysis of cell-free DNA samples</p>

Сохранить в:

Библиографические подробности
Главный автор:	Takafumi Koyama (15035714) (author)
Другие авторы:	Toshio Shimizu (15050147) (author), Yuki Kojima (14182957) (author), Kazuki Sudo (16374908) (author), Hitomi Sumiyoshi Okuma (16540569) (author), Tatsunori Shimoi (16540572) (author), Hitoshi Ichikawa (16540575) (author), Shinji Kohsaka (14957594) (author), Ryo Sadachi (16540578) (author), Akihiro Hirakawa (16540581) (author), Akihiko Yoshida (16540584) (author), Reiko Makihara Ando (16540587) (author), Toshihide Ueno (14946328) (author), Mitsuru Yanagaki (15093837) (author), Naoko Matsui (16540590) (author), Kenichi Nakamura (16540593) (author), Noboru Yamamoto (15013614) (author), Kan Yonemori (15033972) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Small molecule biomarkers Clinical Trial Results Phase II clinical trials Liquid Biopsy Sarcomas Soft-tissue sarcoma
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы